Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201107203 Principal Investigator: Van Tine, Brian
Title: A Phase 1b/2 Randomized Phase 2 Study Evaluating the Efficacy of Doxorubicin With or Without a Human Anti-PDGFRa Monoclonal Antibody (IMC-3G3) in the Treatment of Advanced Soft Tissue Sarcoma
Phase: I/II Disease Site: Soft Tissue
Participating Site(s):
 
Main Campus
Map and Directions		 St. Peters
Map and Directions		 West County
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu
Description:
This study will evaluate the safety of the combination of IMC-3G3 and doxorubicin.

The main purpose of this study is to compare how soft tissue sarcoma responds to treatment with either an investigational agent called IMC-3G3 in combination with doxorubicin or doxorubicin alone.
 
More Information:
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)